SGHT · Sight Sciences, Inc. · Documents

$10.08 +0.32 (+3.28%) At close · Nov 6 Play latest call Q2 2026 earnings call transcript

Russell 2000 member Rebalance outlook locked

Market Cap

$555.51M

55.58M

Volume · Nov 6 576.41K Avg daily vol (3M) 300.98K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $77.36M down 3.1% 10-K filed Mar 4, 2026 Quarterly report New FY2026 Q3 Revenue $24.92M up 25.2% 10-Q filed Nov 4, 2026 Latest results New Financial results 8-K filed Nov 4, 2026 Earnings call Q2 2026 earnings call Held Aug 5, 2026

2026

Nov 4

Quarterly report 10-Q FY2026 Q3, ended Sep 30

Quarterly report for FY2026 Q3 AI summary on its way

Revenue $24.92M ▲ 25.2% Net loss $6.81M Diluted EPS -$0.12

Nov 4

Current report 8-K

Financial results, Regulation FD disclosure AI summary on its way

Sep 15

Investor event

Morgan Stanley 24th Annual Global Healthcare Conference AI summary on its way

Aug 10

Current report 8-K Events of Aug 6

Director or officer change, or executive pay AI summary on its way

Aug 5

Earnings call

Q2 2026 earnings call AI summary on its way

Aug 5

Current report 8-K

Financial results, Regulation FD disclosure AI summary on its way

Aug 5

Quarterly report 10-Q FY2026 Q2, ended Jun 30

Quarterly report for FY2026 Q2 AI summary on its way

Revenue $23.39M ▲ 19.5% Net loss $4.45M Diluted EPS -$0.08

Jun 5

Current report 8-K Events of Jun 4

Shareholder vote results AI summary on its way

May 13

Investor event

BofA Securities Global Health Care Conference 2026 AI summary on its way

May 6

Earnings call

Q1 2026 earnings call AI summary on its way

May 6

Current report 8-K

Financial results, Regulation FD disclosure AI summary on its way

May 6

Quarterly report 10-Q FY2026 Q1, ended Mar 31

Quarterly report for FY2026 Q1 AI summary on its way

Revenue $19.7M ▲ 12.5% Net loss $12.98M Diluted EPS -$0.24

Apr 23

Current report 8-K Events of Apr 22

Regulation FD disclosure AI summary on its way

Apr 22

Proxy statement DEF 14A Meeting Jun 4, 2026

Proxy statement AI summary on its way

Apr 22

Proxy statement DEFA14A

Proxy statement AI summary on its way

Mar 30

Current report 8-K Events of Mar 27

Regulation FD disclosure AI summary on its way

Mar 4

Earnings call

Q4 2025 earnings call AI summary on its way

Mar 4

Current report 8-K

Financial results, Regulation FD disclosure AI summary on its way

Mar 4

Annual report 10-K FY2025, ended Dec 31

Annual report for FY2025 AI summary on its way

Revenue $77.36M ▼ 3.1% Net loss $38.43M Diluted EPS -$0.74

Feb 3

Current report 8-K Events of Jan 29

Entered into a material agreement AI summary on its way

Jan 13

Current report 8-K

Financial results AI summary on its way

2025

Nov 6

Earnings call

Q3 2025 earnings call

Nov 6

Current report 8-K Events of Nov 4

Financial results, Director or officer change, or executive pay, Regulation FD disclosure

Nov 6

Quarterly report 10-Q FY2025 Q3, ended Sep 30

Quarterly report for FY2025 Q3

Revenue $19.91M ▼ 1.2% Net loss $8.17M Diluted EPS -$0.16

Oct 17

Current report 8-K

Regulation FD disclosure, Other events

Sep 30

Current report 8-K

Entered into a material agreement

Aug 27

Current report 8-K

Exit or restructuring costs, Director or officer change, or executive pay, Regulation FD disclosure

Aug 7

Earnings call

Q2 2025 earnings call

Aug 7

Current report 8-K

Financial results, Regulation FD disclosure

Aug 7

Quarterly report 10-Q FY2025 Q2, ended Jun 30

Quarterly report for FY2025 Q2

Revenue $19.56M ▼ 8.5% Net loss $11.94M Diluted EPS -$0.23

Jun 5

Current report 8-K

Director or officer change, or executive pay, Shareholder vote results

May 8

Earnings call

Q1 2025 earnings call

May 8

Current report 8-K

Financial results, Regulation FD disclosure

May 8

Quarterly report 10-Q FY2025 Q1, ended Mar 31

Quarterly report for FY2025 Q1

Revenue $17.51M ▼ 9.1% Net loss $14.15M Diluted EPS -$0.28

Apr 23

Proxy statement DEF 14A Meeting Jun 5, 2025

Proxy statement

Apr 23

Proxy statement DEFA14A

Proxy statement

Apr 22

Current report 8-K Events of Apr 21

Director or officer change, or executive pay, Regulation FD disclosure

Mar 7

Annual report 10-K FY2024, ended Dec 31

Annual report for FY2024

Revenue $79.87M ▼ 1.5% Net loss $51.51M Diluted EPS -$1.03

Mar 5

Current report 8-K

Financial results, Regulation FD disclosure

Jan 28

Current report 8-K Events of Jan 24

Director or officer change, or executive pay

Jan 14

Earnings call

Q4 2024 earnings call

Jan 14

Current report 8-K

Financial results

2024

Dec 11

Current report 8-K

New debt or off-balance-sheet obligation, Unregistered sale of equity

Nov 7

Earnings call

Q3 2024 earnings call

Nov 7

Current report 8-K Events of Nov 1

Financial results, Director or officer change, or executive pay, Regulation FD disclosure

Nov 7

Quarterly report 10-Q FY2024 Q3, ended Sep 30

Quarterly report for FY2024 Q3

Revenue $20.16M ▲ 0.7% Net loss $11.07M Diluted EPS -$0.22

Oct 3

Current report 8-K

Other events

Sep 26

Current report 8-K

Other events

Aug 2

Quarterly report 10-Q FY2024 Q2, ended Jun 30

Quarterly report for FY2024 Q2

Revenue $21.37M ▼ 9.0% Net loss $12.33M Diluted EPS -$0.25

Aug 1

Earnings call

Q2 2024 earnings call

Showing 1–50 of 127 documents

Key facts CIK 1531177 CUSIP 82657M105 13F (30d) 50 filings 38 filers Visit website Investor relations